Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Mar 10;160(5):187-192.
doi: 10.1016/j.medcli.2022.06.020. Epub 2022 Aug 10.

COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study

[Article in English, Spanish]
Mohammad Rahmani  1 , Abdorreza Naser Moghadasi  2 , Shayan Shahi  3 , Sharareh Eskandarieh  2 , Hossein Azizi  4 , Alireza Hasanzadeh  4 , Ali Ahmadzade  4 , Ali Zare Dehnavi  5 , Ramin Hamidi Farahani  6 , Mohammad Aminianfar  7 , Alireza Ranjbar Naeini  8
Affiliations

COVID-19 and its implications on the clinico-radiological course of multiple sclerosis: A case-control study

[Article in English, Spanish]
Mohammad Rahmani et al. Med Clin (Barc). .

Abstract
in English, Spanish

Background: Multiple sclerosis (MS) is an immune-mediated disease that has been related to several risk factors such as various viral infections. We carried out this study in order to establish a relationship between COVID-19 infection and MS severity.

Methods: In a case-control study, we recruited patients with relapsing-remitting multiple sclerosis (RRMS). Patients were divided into two groups based on positive COVID-19 PCR at the end of the enrollment phase. Each patient was prospectively followed for 12 months. Demographical, clinical, and past medical history were collected during routine clinical practice. Assessments were performed every six months; MRI was performed at enrollment and 12 months later.

Results: Three hundred and sixty-two patients participated in this study. MS patients with COVID-19 infection had significantly higher increases in the number of MRI lesions (p: 0.019, OR(CI): 6.37(1.54-26.34)) and EDSS scores (p: 0.017), but no difference was found in total annual relapses or relapse rates. COVID-19 infections were positively correlated with EDSS progression (p: 0.02) and the number of new MRI lesions (p: 0.004) and predicted the likelihood of the number of new MRI lesions by an odds of 5.92 (p: 0.018).

Conclusion: COVID-19 may lead to higher disability scores in the RRMS population and is associated with developing new Gd-enhancing lesions in MRI imaging. However, no difference was observed between the groups regarding the number of relapses during follow-up.

Antecedentes: La esclerosis múltiple (EM) es una enfermedad inmunomediada que se ha relacionado con varios factores de riesgo, como diversas infecciones virales. Realizamos este estudio para establecer una relación entre la infección por COVID-19 y la gravedad de la EM.

Métodos: En un estudio de casos y controles, reclutamos pacientes con esclerosis múltiple remitente-recurrente (EMRR). Los pacientes se dividieron en dos grupos según la PCR positiva para COVID-19 al final de la fase de inscripción. Cada paciente fue seguido prospectivamente durante 12 meses. Los antecedentes demográficos, clínicos y médicos anteriores se recogieron durante la práctica clínica habitual. Las evaluaciones se realizaron cada 6 meses. La resonancia magnética se realizó en el momento de la inscripción y 12 meses después.

Resultados: Trescientos sesenta y dos pacientes participaron en este estudio. Los pacientes con EM con infección por COVID-19 tuvieron aumentos significativamente más altos en el número de lesiones de resonancia magnética (p = 0,019; OR = 6,37 [IC 95%: 1,54-26,34]) y puntajes EDSS (p = 0,017), pero no se encontraron diferencias en el total de recaídas anuales o en las tasas de recaída. Las infecciones por COVID-19 se correlacionaron positivamente con la progresión de EDSS (p = 0,02) y la cantidad de nuevas lesiones en la resonancia magnética (p = 0,004) y predijeron la probabilidad de la cantidad de nuevas lesiones en la resonancia magnética con una probabilidad de 5,92 (p = 0,018).

Conclusión: COVID-19 puede conducir a puntajes de discapacidad más altos en la población de EMRR y está asociado con el desarrollo de nuevas lesiones realzadas con Gd en imágenes de resonancia magnética. Sin embargo, no se observó diferencia entre los grupos en cuanto al número de recaídas durante el seguimiento.

Keywords: COVID-19; EDSS; Enhancing lesions; Esclerosis múltiple; Multiple sclerosis; Progresión; Progression; Realce de lesiones; Recaída; Relapse.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Gilden D.H. Multiple sclerosis exacerbations and infection. Lancet Neurol. 2002;1:145. doi: 10.1016/S1474-4422(02)00066-2. - DOI - PubMed
    1. Donati D. Viral infections and multiple sclerosis. Drug Discov Today Dis Mod. 2020 - PMC - PubMed
    1. Katz Sand I. Classification, diagnosis, and differential diagnosis of multiple sclerosis. Curr Opin Neurol. 2015;28:193–205. doi: 10.1097/wco.0000000000000206. - DOI - PubMed
    1. Kurtzke J.F. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS) Neurology. 1983;33:1444–1452. doi: 10.1212/wnl.33.11.1444. - DOI - PubMed
    1. Brisset J.C., Vukusic S., Cotton F. Update on brain MRI for the diagnosis and follow-up of MS patients. Presse Med. 2021;50:104067. doi: 10.1016/j.lpm.2021.104067. - DOI - PubMed

MeSH terms